← All trials
NCT04517396
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 18, 2020
- Primary completion
- Aug 31, 2021
- Completion date
- Aug 31, 2021
- First posted
- Aug 18, 2020
- Last posted
- Dec 11, 2020
- Enrollment
- 300
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of PennsylvaniaLead sponsor
- University of PennsylvaniaReponsible party - principal investigator
- University of ArizonaCollaborator
- National Center for Advancing Translational Science (NCATS)Collaborator
- Aristotle University of ThessalonikiCollaborator
- University General Hospital of AlexandroupolisCollaborator
- Clínica de Marly. Bogotá, ColombiaCollaborator
- Clinica Internacional. Lima, PeruCollaborator
- Universidad Católica de Santa MaríaCollaborator
- Universidad de SantanderCollaborator
- Fundación Cardiomet. Quindio, ColombiaCollaborator
- Fundación Oftalmológica de Santander. Santander, ColombiaCollaborator
- University of AthensCollaborator
- Hospital 2 de Mayo. Lima, PeruCollaborator
- Hospital de la Fuerza Aérea del Perú. Lima, PeruCollaborator
- University of GuadalajaraCollaborator
- Hospital Militar Central "Coronel Luis Arias Schereiber"; Lima, PerúCollaborator
- Hospital Nacional Adolfo Guevara Velasco, PeruCollaborator
- Hospital Nacional Alberto Sabogal Sologuren, PeruCollaborator
- Hospital Nacional Carlos Alberto Seguin Escobedo - EsSaludCollaborator
- Hospital Nacional Edgardo Rebagliati MartinsCollaborator
- Hospital Nacional Guillermo Almenara Irigoyen, PeruCollaborator
- Athens General Hospital of Thoracic Diseases SOTIRIACollaborator
- Hospital Victor Lazarte Echegaray. Lima, PeruCollaborator
- Ioannina University HospitalCollaborator
- IPS Centro Científico Asistencial. Barranquilla, ColombiaCollaborator
- Thriasion Elefsis General HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.